The Benefit of a Complete over a Successful Reperfusion Decreases with Time
Annals of Neurology · 2023
DOI: 10.1002/ana.26599 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Neurology, 2023. Verfasst von Benjamin Maïer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Hôpital Saint-Joseph, Paris, France. Hauptthemen laut MEDLINE: Brain Ischemia, Endovascular Procedures, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
Time from stroke onset to reperfusion (TSOR) is strongly associated with outcomes after endovascular treatment. A near‐to‐complete or complete reperfusion (modified Treatment in Cerebral Ischemia [mTICI] 2c–3) is associated with improved outcomes compared with a successful reperfusion (mTICI 2b). However, it is unknown whether this association remains stable as TSOR increases. Therefore, we sought to investigate the association between TSOR and outcomes according to the reperfusion status.
Methods
We analyzed data from the Endovascular Treatment in Ischemic Stroke registry, a prospective, observational, multicentric study of acute ischemic stroke patients treated with endovascular treatment in 21 centers in France. We included patients with anterior occlusions (M1, internal carotid artery, tandem), with a known time of symptom onset. Outcomes were early neurological improvement at 24 hours and favorable outcome (modified Rankin Scale between 0 and 2) at 90 days.
Results
Overall, 4,444 patients were analyzed. Compared with a mTICI 2b, a mTICI 2c‐3 at 1 hour was associated with higher mean marginal probabilities of early neurological improvement (25.6%, 95% CI 11.7–39.5, p = 0.0003) and favorable outcome (15.2%, 95% CI 3.0–27.4, p = 0.0143), and progressively declined with TSOR. The benefit of a mTICI 2c‐3 over a mTICI 2b was no longer significant regarding the rates of early neurological improvement and favorable outcome after a TSOR of 414 and 344 minutes, respectively.
Interpretation
The prognostic value of a complete over a successful reperfusion progressively declined with time, and no difference regarding the rates of favorable outcome was observed between a complete and successful reperfusion beyond 5.7 hours. ANN NEUROL 2023;93:934–941
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Neurology Department, Hôpital Saint-Joseph, Paris, France.
- Interventional Neuroradiology Department, Hôpital Fondation A. de Rothschild, Paris, France.
- Université Paris-Cité, Paris, France.
- Université Paris-Cité and Université Sorbonne Paris Nord, INSERM U1148, LVTS, Paris, France.
- Aristotle University of Thessaloniki, Ahepa Hospital, Thessaoniki, Greece.
- Neurology Department, Hôpital Lariboisière, Paris, France.
ORCID-Profile: Benjamin Maïer, Benjamin Gory, Jean-Marc Olivot
Zitieren
APA
Maïer, B., Finitsis, S., Mazighi, M., Lapergue, B., Marnat, G., Sibon, I., Richard, S., Viguier, A., Cognard, C., Gory, B., Olivot, J. M., & ETIS Registry Investigators (2023). The Benefit of a Complete over a Successful Reperfusion Decreases with Time. Annals of Neurology. https://doi.org/10.1002/ana.26599
Vancouver
Maïer B, Finitsis S, Mazighi M, Lapergue B, Marnat G, Sibon I, et al. The Benefit of a Complete over a Successful Reperfusion Decreases with Time. Annals of Neurology. 2023. doi:10.1002/ana.26599
BibTeX
@article{Maer2023,
author = {Maïer, Benjamin and Finitsis, Stephanos and Mazighi, Mikael and Lapergue, Bertrand and Marnat, Gaultier and Sibon, Igor and Richard, Sebastien and Viguier, Alain and Cognard, Christophe and Gory, Benjamin and Olivot, Jean-Marc and ETIS Registry Investigators, ETIS Registry Investigators},
title = {The Benefit of a Complete over a Successful Reperfusion Decreases with Time},
journal = {Annals of Neurology},
year = {2023},
doi = {10.1002/ana.26599}
}
EUVIMED